30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kenneth Mills

Track

Insider profile

Currently holds a position at Regenxbio Inc

Positions

Position Company Period
President, Chief Executive Officer, Executive Director Regenxbio Inc March 1, 2009 -
Kenneth Mills's trades of Regenxbio Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-14 2025-05-12
US Regenxbio Inc (RGNX)
PlS Planned sale
88,480 +33.1%
189.85
US$2,702,512 		88,480 +33.1% 189.85 US$2,702,512
2025-05-12 2025-05-12
US Regenxbio Inc (RGNX)
PrS Proposed sale
96,173
361.85
US$2,415,198 		96,173 361.85 US$2,415,198
2024-07-26 2024-07-25
US Regenxbio Inc (RGNX)
PlS Planned sale
9,466 -28.7%
464.11
US$3,155,230 		9,466 -28.7% 464.11 US$3,155,230
2024-07-26 2024-07-24
US Regenxbio Inc (RGNX)
PlS Planned sale
12,221 -2.9%
13.78
US$168,433 		12,221 -2.9% 13.78 US$168,433
2024-07-18 2024-07-17
US Regenxbio Inc (RGNX)
PlS Planned sale
2,210 -0.5%
13.77
US$30,440 		2,210 -0.5% 13.77 US$30,440
2024-07-18 2024-07-16
US Regenxbio Inc (RGNX)
PlS Planned sale
200 -0.0%
13.76
US$2,752 		200 -0.0% 13.76 US$2,752
2024-05-16 2024-05-14
US Regenxbio Inc (RGNX)
PlS Planned sale
15,000 -3.5%
15.81
US$237,222 		15,000 -3.5% 15.81 US$237,222
2024-05-14 2024-05-14
US Regenxbio Inc (RGNX)
PrS Proposed sale
45,000
15.74
US$708,300 		45,000 15.74 US$708,300
2024-04-17 2024-04-15
US Regenxbio Inc (RGNX)
PlS Planned sale
15,000 -3.5%
18.19
US$272,871 		15,000 -3.5% 18.19 US$272,871
2024-03-18 2024-03-14
US Regenxbio Inc (RGNX)
PlS Planned sale
15,000 -3.5%
21.86
US$327,942 		15,000 -3.5% 21.86 US$327,942
2024-02-16 2024-02-14
US Regenxbio Inc (RGNX)
PlS Planned sale
10,348 -2.5%
16.88
US$174,723 		10,348 -2.5% 16.88 US$174,723
2024-02-16 2024-02-14
US Regenxbio Inc (RGNX)
PlS Planned sale
4,652 -1.1%
16.47
US$76,626 		4,652 -1.1% 16.47 US$76,626
2024-01-18 2024-01-16
US Regenxbio Inc (RGNX)
PlS Planned sale
45,000 -9.9%
15.18
US$682,992 		45,000 -9.9% 15.18 US$682,992
2024-01-16 2024-01-16
US Regenxbio Inc (RGNX)
PrS Proposed sale
90,000
15.13
US$1,361,700 		90,000 15.13 US$1,361,700
2023-12-21 2023-12-19
US Regenxbio Inc (RGNX)
PlS Planned sale
45,000 -11.2%
19.69
US$885,825 		45,000 -11.2% 19.69 US$885,825
2023-12-19 2023-12-19
US Regenxbio Inc (RGNX)
PrS Proposed sale
45,000
19.51
US$877,950 		45,000 19.51 US$877,950
2021-11-10 2021-11-08
US Regenxbio Inc (RGNX)
PlS Planned sale
1,500 -0.5%
40.00
US$60,000 		1,500 -0.5% 40.00 US$60,000
2021-09-29 2021-09-27
US Regenxbio Inc (RGNX)
PlS Planned sale
1,500 -0.5%
42.19
US$63,285 		1,500 -0.5% 42.19 US$63,285
2021-06-28 2021-06-25
US Regenxbio Inc (RGNX)
PlS Planned sale
1,500 -0.5%
40.25
US$60,375 		1,500 -0.5% 40.25 US$60,375
2021-06-28 2021-06-24
US Regenxbio Inc (RGNX)
PlS Planned sale
4,500 -1.6%
40.02
US$180,090 		4,500 -1.6% 40.02 US$180,090
2021-03-01 2021-02-25
US Regenxbio Inc (RGNX)
PlS Planned sale
1,500 -0.5%
40.77
US$61,155 		1,500 -0.5% 40.77 US$61,155
2021-01-27 2021-01-25
US Regenxbio Inc (RGNX)
PlS Planned sale
5,211 -1.8%
44.99
US$234,443 		5,211 -1.8% 44.99 US$234,443
2021-01-27 2021-01-25
US Regenxbio Inc (RGNX)
PlS Planned sale
974 -0.3%
44.05
US$42,905 		974 -0.3% 44.05 US$42,905
2021-01-27 2021-01-25
US Regenxbio Inc (RGNX)
PlS Planned sale
315 -0.1%
42.64
US$13,432 		315 -0.1% 42.64 US$13,432
2021-01-11 2021-01-07
US Regenxbio Inc (RGNX)
PlS Planned sale
1,500 -0.5%
50.01
US$75,015 		1,500 -0.5% 50.01 US$75,015
2020-12-30 2020-12-28
US Regenxbio Inc (RGNX)
PlS Planned sale
1,853 -0.8%
49.16
US$91,093 		1,853 -0.8% 49.16 US$91,093
2020-12-30 2020-12-28
US Regenxbio Inc (RGNX)
PlS Planned sale
4,647 -1.9%
48.47
US$225,240 		4,647 -1.9% 48.47 US$225,240
2020-12-28 2020-12-23
US Regenxbio Inc (RGNX)
PlS Planned sale
4,500 -1.8%
50.00
US$225,000 		4,500 -1.8% 50.00 US$225,000
2020-12-18 2020-12-16
US Regenxbio Inc (RGNX)
PlS Planned sale
15,000 -5.9%
45.00
US$675,000 		15,000 -5.9% 45.00 US$675,000
2020-12-14 2020-12-10
US Regenxbio Inc (RGNX)
PlS Planned sale
4,500 -1.8%
40.00
US$180,000 		4,500 -1.8% 40.00 US$180,000
2019-09-23 2019-09-19
US Regenxbio Inc (RGNX)
PlS Planned sale
7,773 -3.1%
39.91
US$310,220 		7,773 -3.1% 39.91 US$310,220
2019-09-23 2019-09-19
US Regenxbio Inc (RGNX)
PlS Planned sale
2,227 -0.9%
39.19
US$87,276 		2,227 -0.9% 39.19 US$87,276
2019-07-23 2019-07-19
US Regenxbio Inc (RGNX)
PlS Planned sale
2,300 -0.9%
49.97
US$114,931 		2,300 -0.9% 49.97 US$114,931
2019-07-23 2019-07-19
US Regenxbio Inc (RGNX)
PlS Planned sale
12,700 -4.9%
49.40
US$627,380 		12,700 -4.9% 49.40 US$627,380
2019-06-21 2019-06-19
US Regenxbio Inc (RGNX)
PlS Planned sale
4,120 -1.6%
53.25
US$219,390 		4,120 -1.6% 53.25 US$219,390
2019-06-21 2019-06-19
US Regenxbio Inc (RGNX)
PlS Planned sale
10,880 -4.2%
52.27
US$568,698 		10,880 -4.2% 52.27 US$568,698
2019-05-22 2019-05-20
US Regenxbio Inc (RGNX)
PlS Planned sale
300 -0.1%
43.99
US$13,197 		300 -0.1% 43.99 US$13,197
2019-05-22 2019-05-20
US Regenxbio Inc (RGNX)
PlS Planned sale
10,559 -4.1%
43.32
US$457,416 		10,559 -4.1% 43.32 US$457,416
2019-05-22 2019-05-20
US Regenxbio Inc (RGNX)
PlS Planned sale
4,141 -1.6%
42.08
US$174,253 		4,141 -1.6% 42.08 US$174,253
2019-04-24 2019-04-22
US Regenxbio Inc (RGNX)
PlS Planned sale
100 -0.0%
53.05
US$5,305 		100 -0.0% 53.05 US$5,305
2019-04-24 2019-04-22
US Regenxbio Inc (RGNX)
PlS Planned sale
1,300 -0.5%
52.33
US$68,029 		1,300 -0.5% 52.33 US$68,029
2019-04-24 2019-04-22
US Regenxbio Inc (RGNX)
PlS Planned sale
3,270 -1.3%
51.07
US$166,999 		3,270 -1.3% 51.07 US$166,999
2019-04-24 2019-04-22
US Regenxbio Inc (RGNX)
PlS Planned sale
6,929 -2.7%
50.31
US$348,598 		6,929 -2.7% 50.31 US$348,598
2019-04-24 2019-04-22
US Regenxbio Inc (RGNX)
PlS Planned sale
3,401 -1.3%
49.29
US$167,635 		3,401 -1.3% 49.29 US$167,635
2019-03-21 2019-03-19
US Regenxbio Inc (RGNX)
PlS Planned sale
9,130 -3.6%
58.74
US$536,296 		9,130 -3.6% 58.74 US$536,296